PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Keystone, Edward
TI  - The Reflex Study: Prevention of Joint Structural Damage at 1 Year with Rituximab in Rheumatoid Arthritis Patients with an Inadequate Response to One or More TNF Inhibitors
DP  - 2006 Oct 01
TA  - MD Conference Express
PG  - 13--13
VI  - 6
IP  - 3
4099  - http://mdc.sagepub.com/content/6/3/13.2.short
4100  - http://mdc.sagepub.com/content/6/3/13.2.full
AB  - Previous reports of the Reflex Study 6-month data with rituximab (RTX) indicated that this selective CD20+ B cell targeted therapy can inhibit the radiographic progression of joint structural damage in RA patients with longstanding resistance to one or more TNF inhibitors [Cohen et al. Arthritis Rheum in press).